Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
暂无分享,去创建一个
[1] R. Lafayette,et al. Anaritide in Acute Tubular Necrosis , 1997 .
[2] G. Fuiano,et al. Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients. , 1997, Journal of the American Society of Nephrology : JASN.
[3] R. Dietz,et al. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. , 1996, Hypertension.
[4] E. Fleck,et al. Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. , 1995, Hypertension.
[5] M. Burnier,et al. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension , 1995, Journal of hypertension.
[6] J. Stasch,et al. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.
[7] F. Pieruzzi,et al. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. , 1995, Hypertension.
[8] R. Mayfield,et al. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. , 1994, Hypertension.
[9] K. Shimamoto,et al. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats. , 1994, Clinical and experimental hypertension.
[10] J. Scott,et al. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats. , 1993, European journal of pharmacology.
[11] G. Wittert,et al. Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II , 1993, Journal of hypertension.
[12] I. Ichikawa,et al. Biological significance of atrial natriuretic peptide in the kidney. , 1993, Nephron.
[13] D. Goeddel,et al. Molecular Biology of the Natriuretic Peptides and Their Receptors , 1992, Circulation.
[14] E. Ongini,et al. The Neutral Endopeptidase Inhibitor, SCH 34826, Reduces Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats , 1992, Journal of cardiovascular pharmacology.
[15] D. de Zeeuw,et al. Atrial natriuretic factor: its (patho)physiological significance in humans. , 1992, Kidney international.
[16] N. Markandu,et al. Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension? , 1992, Journal of hypertension.
[17] O. Vuolteenaho,et al. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand. , 1992, Endocrinology.
[18] K. Margulies,et al. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. , 1991, The Journal of clinical investigation.
[19] G. Wittert,et al. Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects. , 1991, Journal of hypertension.
[20] N. Trippodo,et al. Heart Failure Augments the Cardiovascular and Renal Effects of Neutral Endopeptidase Inhibition in Rats , 1991, Journal of cardiovascular pharmacology.
[21] M. Burnier,et al. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers , 1991, Clinical pharmacology and therapeutics.
[22] I. Tikkanen,et al. Prolonged neutral endopeptidase inhibition in heart failure. , 1991, European journal of pharmacology.
[23] K. Margulies,et al. ANF-mediated renal cGMP generation in congestive heart failure. , 1991, The American journal of physiology.
[24] J. Hunt,et al. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. , 1991, The Journal of pharmacology and experimental therapeutics.
[25] K. Margulies,et al. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. , 1990, Circulation.
[26] P. Hamet,et al. Atrial natriuretic peptide--cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man. , 1990, Canadian journal of physiology and pharmacology.
[27] P. Chiu,et al. Atrial Natriuretic Factor‐Potentiating and Antihypertensive Activity of SCH 34826: An Orally Active Neutral Metalloendopeptidase Inhibitor , 1990, Hypertension.
[28] G. Dibona,et al. Renal and hemodynamic effects of atrial natriuretic peptide in patients with cirrhosis. , 1990, The American journal of the medical sciences.
[29] K. James,et al. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. , 1989, Biochemical and biophysical research communications.
[30] E. H. Blaine,et al. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats. , 1989, The Journal of pharmacology and experimental therapeutics.
[31] T. Inagami,et al. Atrial natriuretic factor. , 1989, The Journal of biological chemistry.
[32] R. Skidgel,et al. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] R. Ogilvie,et al. Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. , 1989, Circulation.
[34] M. Wilkins,et al. Urinary guanosine 3':5'-cyclic monophosphate but not tissue kallikrein follows the plasma atrial natriuretic factor response to acute volume expansion with saline. , 1988, Clinical science.
[35] J. Lewicki,et al. Physiological role of silent receptors of atrial natriuretic factor. , 1987, Science.
[36] M. Cantin,et al. Role of right and left atria in natriuresis and atrial natriuretic factor release during blood volume changes in the conscious rat. , 1987, Circulation research.
[37] Y. Kabayama,et al. Stimulation by volume expansion of atrial natriuretic peptide release from perfused rat heart , 1987, Peptides.
[38] M. Cantin,et al. Atrial natriuretic factor in human plasma. , 1986, Biochemical and biophysical research communications.
[39] E. Schiffrin,et al. Cyclic GMP as mediator and biological marker of atrial natriuretic factor. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[40] F. Murad,et al. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. , 1984, The Journal of biological chemistry.
[41] M. Cantin,et al. Effect of native and synthetic atrial natriuretic factor on cyclic GMP. , 1984, Biochemical and biophysical research communications.
[42] P. Hamet,et al. Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates. , 1980, Journal of cyclic nucleotide research.